Related Experiment Video
Updated: Jul 13, 2026

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
Published on: February 9, 2024
P14ARF sensitizes human osteosarcoma cells to cisplatin-induced apoptosis in a p53-independent manner
Xiang-Wei Yuan1, Xiao-Feng Zhu, Xiu-Fang Huang
1Department of Orthopedic Surgery, The First Affiliated Hospital, Cancer Center, Sun Yat-sen University, Guangzhou, PR China.
Abstract:
The tumor suppressor p14ARF, encoded by the INK4a/ARF locus, is often disrupted in human cancers, p14ARF triggers cell cycle arrest and sensitizes cells to apoptosis in the presence of collateral signals. To investigate the role of p14ARF in chemotherapeutic drugs-induced apoptosis, p14ARF was overexpressed by stable transfection in human osteosarcoma cell lines, U2OS (p53-wt/p14ARF-null) and MG63 (p53-mt/p14ARF-null). The results showed that ectopic p14ARF sensitized both cell lines to cisplatin-induced cytotoxicity and apoptosis. This sensitization of cisplatin-induced apoptosis was associated with upregulation of p53, Bax and p21 in U2OS cells. Conversely, such a result was not observed in MG63 cells. Moreover, the sensitization of cisplatin-induced cytotoxicity in U2OS cells was unaltered by p53 siRNA. Together, we show here p14ARF sensitizes human osteosarcoma cells to cisplatin-induced apoptosis in a p53-independent manner. Proper combinations of p14ARF gene transfer and conventional chemotherapy may be a valuable strategy in human osteosarcoma treatment.
Insights
The tumor suppressor p14ARF enhances apoptosis in osteosarcoma cells treated with cisplatin. This effect is independent of p53, suggesting p14ARF gene therapy combined with chemotherapy could treat osteosarcoma.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- The tumor suppressor p14ARF, encoded by the INK4a/ARF locus, plays a critical role in cell cycle arrest and apoptosis.
- Disruption of p14ARF is common in human cancers, impacting therapeutic responses.
Purpose of the Study:
- To investigate the role of p14ARF in mediating apoptosis induced by chemotherapeutic drugs.
- To explore the potential of p14ARF as a therapeutic agent in osteosarcoma.
Main Methods:
- Overexpression of p14ARF in human osteosarcoma cell lines (U2OS and MG63) via stable transfection.
- Assessment of cell sensitivity to cisplatin-induced cytotoxicity and apoptosis.
- Analysis of p53, Bax, and p21 expression levels.
- Evaluation of p53's role using p53 siRNA.
Main Results:
- Ectopic p14ARF expression sensitized both U2OS and MG63 cells to cisplatin-induced cytotoxicity and apoptosis.
- In U2OS cells, sensitization correlated with increased p53, Bax, and p21.
- This sensitization effect in U2OS cells was independent of p53 status, as confirmed by p53 siRNA experiments.
Conclusions:
- p14ARF sensitizes human osteosarcoma cells to cisplatin-induced apoptosis through a p53-independent pathway.
- Combining p14ARF gene transfer with conventional chemotherapy presents a promising strategy for osteosarcoma treatment.
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
The Intrinsic Apoptotic Pathway
